top of page
Writer's pictureMarcel Filart

New Antiviral drug for COVID-19 treatment gets FDA Emergency Use Authorization !

Updated: May 2, 2020

Remdesivir an experimental drug developed by Gilead as a treatment for Ebola virus disease. (used in trials in Liberia known as PREVAIL 4). Remdesivir is no longer being administered to patients with Ebola virus..


Remdesivir is FDA approved for SEVERE Covid-19 pneumonia in hospitalized patients. Dose: 200 mg IV on day 1 then 100mg IV once daily for up to 10 days.


“FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step forward in battling COVID-19 and another example of the Trump Administration moving as quickly as possible to use science to save lives,” said HHS Secretary Alex Azar



109 views1 comment

Recent Posts

See All

1 Comment


Maddy Joun
Maddy Joun
Aug 24, 2022

Wow! This is very good news the new Antiviral drug for covid-19 treatment gets FDA emergency ese authorization. thanks for sharing this information in your blog post please keep up your great work. If you need ARITHMETIC ASSIGNMENT HELP ONLINE so contact him because I am a user of this service and they are always help me when I need assignment help and that's why I really like this service.

Like
bottom of page